| Literature DB >> 34946187 |
Brita Askeland Winje1,2, Trine Skogset Ofitserova1, Ola Brønstad Brynildsrud3, Margrethe Greve-Isdahl1, Karoline Bragstad4, Rikard Rykkvin4, Olav Hungnes4, Hilde Marie Lund5, Karin Nygård5, Hinta Meijerink1, Lin Thorstensen Brandal5,6.
Abstract
The role of children in the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in schools has been a topic of controversy. In this study among school contacts of SARS-CoV-2 positive children in 43 contact-investigations, we investigated SARS-CoV-2 transmission in Norway, August 2020-May 2021. All participants were tested twice within seven to ten days, using SARS-CoV-2 PCR on home-sampled saliva. Positive samples were whole genome sequenced. Among the 559 child contacts, eight tested positive (1.4%, 95% CI 0.62-2.80), with no significant difference between primary (1.0%, 95% CI 0.27-2.53) and secondary schools (2.6%, 95% CI 0.70-6.39), p = 0.229, nor by viral strain, non-Alpha (1.4%, 95% CI 0.50-2.94) and Alpha variant (B.1.1.7) (1.7%, 95% CI 0.21-5.99), p = 0.665. One adult contact (1/100) tested positive. In 34 index cases, we detected 13 different SARS-CoV-2 Pango lineage variants, with B.1.1.7 being most frequent. In the eight contact-investigations with SARS-CoV-2 positive contacts, four had the same sequence identity as the index, one had no relation, and three were inconclusive. With mitigation measures in place, the spread of SARS-CoV-2 from children in schools is limited. By excluding contact-investigations with adult cases known at the time of enrolment, our data provide a valid estimate on the role of children in the transmission of SARS-CoV-2 in schools.Entities:
Keywords: COVID-19; SARS-CoV-2; child; contact; infection prevention and control; transmission; whole genome sequencing
Year: 2021 PMID: 34946187 PMCID: PMC8705768 DOI: 10.3390/microorganisms9122587
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Overview of study data and data sources.
| Source | Level |
|---|---|
| Home-sampled saliva test, study start * | All participants |
| Home-sampled saliva test, study end * | All participants |
| Questionnaire 1—Demography and previous exposure | All participants |
| Questionnaire 2—Symptom diary | All participants |
| Questionnaire 3—Outcome and exposure | Contacts negative for SARS-CoV-2 in the first saliva sample |
| WGS data-cases * | Cases and contacts with confirmed SARS-CoV-2 |
| Linkage with MSIS laboratory database | All participants |
| Infection prevention and control measures | Participating Schools |
| Outcome of contact investigation, municipalities | Population, aggregated |
| Epidemiological data | Population, aggregated |
WGS: Whole Genome Sequencing, MSIS: Norwegian Surveillance System for Infectious Diseases; * all laboratory analyses were done at the influenza reference laboratory at the Norwegian Institute of Public Health.
Characteristics of the contact-investigations.
| ID I | Quarter/Year | Grade | County | IR (/100,000) $ | IPC II-Level | Child Contacts | Adult Contacts | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| County | Local | National # | Scores (Local) § | Total | Included | Total | Included | ||||
| 1st to 4th grade | |||||||||||
| 1 * | Q3-2020 | 1–4 | Viken | 34 | 17 | 7 | 30 | 15 (50) | 12 | 3 | |
| 2 * | Q3-2020 | 1–4 | Viken | 29 | 26 | 7 | 45 | 33 (73) | 9 | 4 | |
| 3 * | Q3-2020 | 1–4 | Viken | 29 | 26 | 4 | 18 | 16 (89) | 3 | 2 | |
| 4 * | Q4-2020 | 1–4 | Viken | 31 | 39 | 5 | 22 | 19 (86) | 9 | 7 | |
| 5 * | Q4-2020 | 1–4 | Viken | 31 | 51 | 7 | 22 | 17 (77) | 5 | 5 | |
| 6 * | Q4-2020 | 1–4 | Viken | 31 | 51 | 7 | 19 | 4 (21) | 5 | 2 | |
| 7 * | Q4-2020 | 1–4 | Oslo | 99 | 55 | 6 | 22 | 18 (82) | 7 | 7 | |
| 8 * | Q4-2020 | 1–4 | Oslo | 181 | 150 | 5 | 24 | 18 (71) | 4 | 3 | |
| 9 | Q4-2020 | 1–4 | Oslo | 336 | 251 | 6 | 21 | 14 (67) | 1 | 1 | |
| 10 | Q2-2021 | 1–4 | Oslo | 441 | 763 | - | 13 | 4 (31) | 1 | 1 | |
| 11 | Q2-2021 | 1–4 | Oslo | 471 | 433 | 7 | 37 | 20 (54) | 3 | 4 | |
| 12 | Q2-2021 | 1–4 | Oslo | 284 | 267 | 8 | 18 | 13 (72) | 1 | 0 | |
| 13 | Q2-2021 | 1–4 | Viken | 141 | 204 | 7 | 9 | 4 (44) | 1 | 1 | |
| 14 | Q2-2021 | 1–4 | Viken | 118 | 337 | 7 | 10 | 6 (60) | 4 | 1 | |
| 15 | Q2-2021 | 1–4 | Viken | 109 | 152 | 8 | 19 | 13(14) | 3 | 3 | |
| 5th to 7th grade | |||||||||||
| 16 * | Q3-2020 | 5–7 | Oslo | 53 | 65 | 7 | 20 | 17 (85) | 3 | 2 | |
| 17 * | Q4-2020 | 5–7 | Oslo | 99 | 55 | 6 | 25 | 20 (80) | 3 | 2 | |
| 18 * | Q4-2020 | 5–7 | Oslo | 95 | 96 | 6 | 24 | 17 (71) | 6 | 2 | |
| 19 * | Q4-2020 | 5–7 | Oslo | 111 | 111 | 6 | 25 | 8 (28) | 3 | 3 | |
| 20 * | Q4-2020 | 5–7 | Oslo | 181 | 276 | 6 | 21 | 15 (71) | 4 | 3 | |
| 21 | Q4-2020 | 5–7 | Oslo | 254 | 354 | 5 | 16 | 10 (63) | 1 | 0 | |
| 22 | Q4-2020 | 5–7 | Viken | 209 | 522 | 7 | 15 | 9 (60) | 1 | 1 | |
| 23 | Q4-2020 | 5–7 | Viken | 194 | 179 | - | 17 | 14 (82) | 2 | 1 | |
| 24 | Q4-2020 | 5–7 | Viken | 182 | 158 | 7 | 18 | 10 (56) | 0 | 0 | |
| 25 | Q1-2021 | 5–7 | Viken | 144 | 201 | 7 | 41 | 31 (76) | 2 | 1 | |
| 26 | Q1-2021 | 5–7 | Viken | 144 | 171 | 7 | 20 | 15 (70) | 5 | 2 | |
| 27 | Q2-2021 | 5–7 | Oslo | 363 | 211 | 8 | 10 | 4 (40) | 1 | 0 | |
| 28 | Q2-2021 | 5–7 | Oslo | 284 | 419 | - | 14 | 6 (43) | 3 | 1 | |
| 29 | Q2-2021 | 5–7 | Oslo | 212 | 179 | 7 | 24 | 12 (50) | 4 | 2 | |
| 8th to10th grade | |||||||||||
| 30 | Q4-2020 | 8–10 | Oslo | 181 | 150 | 5 | 21 | 16 (76) | 3 | 2 | |
| 31 | Q4-2020 | 8–10 | Oslo | 254 | 354 | 7 | 22 | 3 (14) | 1 | 0 | |
| 31 | Q4-2020 | 8–10 | Oslo | 254 | 429 | 6 | 23 | 12 (52) | 4 | 1 | |
| 33 | Q4-2020 | 8–10 | Oslo | 336 | 438 | 5 | 25 | 14 (56) | 8 | 6 | |
| 34 | Q4-2020 | 8–10 | Oslo | 336 | 415 | 5 | 28 | 19 (68) | 4 | 1 | |
| 35 | Q4-2020 | 8–10 | Oslo | 336 | 415 | 6 | 19 | 4 (16) | 5 | 3 | |
| 36 | Q4-2020 | 8–10 | Oslo | 294 | 239 | 8 | 13 | 5 (38) | 4 | 1 | |
| 37 | Q4-2020 | 8–10 | Viken | 194 | 179 | - | 18 | 10 (56) | 3 | 1 | |
| 38 | Q4-2020 | 8–10 | Oslo | 223 | 365 | 8 | 23 | 17 (74) | 2 | 2 | |
| 39 | Q1-2021 | 8–10 | Viken | 202 | 268 | 7 | 14 | 6 (50) | 1 | 2 | |
| 40 | Q1-2021 | 8–10 | Viken | 190 | 159 | 8 | 10 | 6 (60) | 5 | 1 | |
| 41 | Q1-2021 | 8–10 | Viken | 190 | 269 | 6 | 20 | 9 (45) | 1 | 1 | |
| 42 | Q1-2021 | 8–10 | Viken | 195 | 335 | 7 | 62 | 32 (52) | 6 | 3 | |
| 43 | Q1-2021 | 8–10 | Oslo | 471 | 637 | 7 | 18 | 4 (22) | 3 | 3 | |
I ID; identifier for each contact-investigation; * A subset of the data from the contact-investigations ID number 1–12 and 14 have been published earlier [7]; $ IR (/100,000) the last 14 days prior to date of clinical sample collection of the index case in Oslo and Viken counties and in communities or boroughs (local); II IPC; Infection Prevention and Control measures; # National Infection Prevention and Control guidelines for schools used a traffic light model based on infection pressure to indicate level of IPC measures. Red light implies strongest containment strategies [9]; § IPC measures in affected schools were classified and scored (0–8) according to a standard format. Higher scores indicates higher consistency with national guidelines. See Appendix A Table A3 for details.
Characteristics of the study population in 43 contact investigations in Oslo and Viken, August 2020 to May 2021.
| Whole Study Period | Pre-Alpha | Alpha | |
|---|---|---|---|
| Number of contact investigations, all ( | 43 | 32 | 11 |
| 1–4th grade | 15 (35) | 9 (28) | 6 (55) |
| 5–7th grade | 14 (33) | 11 (34) | 3 (27) |
| 8–10th grade | 14 (33) | 12 (38) | 2 (18) |
| Number of child contacts, all ( | 599 | 441 | 118 |
| 1–4th grade | 214 (36) | 154 (35) | 60 (51) |
| 5–7th grade | 188 (31) | 166 (38) | 22 (19) |
| 8–10th grade | 157 (26) | 121 (27) | 36 (31) |
| Number of adult contacts, all ( | 100 | 81 | 19 |
| 1–4th grade | 53 (53) | 43 (53) | 10 (53) |
| 5–7th grade | 20 (20) | 17 (21) | 3 (16) |
| 8–10th grade | 27 (27) | 21 (26) | 6 (32) |
| Number of child contacts per index case (median, range) # | 13 (3–33) | 15 (4–33) | 6 (4–32) |
| Participation child contacts (median, range) # | 60 (14–89) | 68 (14–89) | 44 (14–72) |
| Number of adult contacts per index case (median, range) # | 2 (0–12) | 2 (0–12) | 1 (0–3) |
| Participation adult contacts (median, range) # | 67 (0–100) | 67 (0–100) | 50 (0–100) |
| IPC-score (median, range) | 7 (6–8) | 6 (5–8) | 7 (6–8) |
IPC-score, Infection Prevention and Control (mitigation) measures, scored on a scale from 0–8 with higher scores indicating higher consistency with national guidelines; pre-Alpha and Alpha reflects the period before and after the Alpha variant (B.1.1.7) was established (August–February versus March–May); Participation was calculated as the percentage of included contacts of all identified contacts per contact-investigation, presented as median (%) and range (%–%).
Primary, secondary and all infected child contacts detected in school contact investigations (n, 43) within 7–10 days following the last exposure, Oslo and Viken, August 2020–May 2021.
| Number of Contacts, | Primary I Cases, | Secondary II Cases, | All Infected Cases III | |
|---|---|---|---|---|
| All child contacts | 559 (537) | 4 (0.7, 0.20–1.82) | 4 (0.7, 0.20–1.90) | 8 (1.4, 0.62–2.80) |
| pre-Alpha * | 441 (426) | 3 (0.7, 0.14–1.97) | 3 (0.7, 0.15–2.04) | 6 (1.4, 0.50–2.94) |
| Alpha * | 118 (111) | 1 (0.9, 0.02–4.63) | 1 (0.9, 0.02–4.92) | 2 (1.7, 0.21–5.99) |
| Child contacts by school grade | ||||
| Child contacts, grade 1–4 (all) | 214 (206) | 1 (0.5, 0.01–2.58) | 0 | 1 (0.5, 0.01–2.58) |
| pre-Alpha | 154 (148) | 1 (0.7, 0.02–3.56) | 0 | 1 (0.7, 0.02–3.56) |
| Alpha | 60 (58) | 0 | 0 | 0 |
| Child contacts, grade 5–7 (all) | 188 (183) | 1 (0.5, 0.01–2.93) | 2 (1.1, 0.13–3.89) | 3 (1.6, 0.33–4.59) |
| pre-Alpha | 166 (163) | 1 (0.6, 0.02–3.31) | 1 (0.6, 0.02–3.37) | 2 (1.2, 0.15–4.28) |
| Alpha | 22 (20) | 0 | 1 (5.0, 0.13–22.87) | 1 (4.5, 0.12–22.84) |
| Child contacts, grade 8–10 (all) | 157 (148) | 2 (1.3, 0.15–4.53) | 2 (1.4, 0.16–4.58) | 4 (2.6, 0.70–6.39) |
| pre-Alpha | 121 (115) | 1 (0.8, 0.02–4.52) | 2 (1.8, 0.20–6.14) | 3 (2.5 0.51–7.07) |
| Alpha | 36 (33) | 1 (2.8, 0.07–14.5) | 0 | 1 (2.8, 0.07–14.53) |
* pre-Alpha and Alpha reflects the period before and after the Alpha variant (B.1.1.7) was established (August–February versus March–May); # n (n) number of contacts, the parentheses represents the number of contacts with a second saliva sample; 18 (3%) child contacts did not provide a second saliva sample and primary cases were excluded; I a contact of the index case who tested positive for SARS-CoV-2 in the first saliva sample; II a contact of the index case who tested positive for SARS-CoV-2 in the second saliva sample, following a first negative test; III a contact who tested positive for SARS-CoV-2 in either of the two saliva tests, thus including both the primary and secondary cases.
SARS-CoV-2 Pango lineage variants among child index cases (n, 33), Oslo and Viken, August 2020–May 2021.
| SARS-CoV-2 Variant I | Number of Contact | Time of Contact-Investigation | Period # |
|---|---|---|---|
| B.1.1.7 | 7 | April 2021–May 2021 | Alpha |
| B.1.36.21 | 6 | November 2020–January 2021 | pre-Alpha |
| K.3 | 5 | October 2020 | pre-Alpha |
| B.1.367 | 3 | September 2020–October 2020 | pre-Alpha |
| B.1.1.305 | 3 | December 2020–January 2021 | pre-Alpha |
| B.1.1 | 2 | November 2020–January 2021 | pre-Alpha |
| Other * | 7 | September 2020–January 2021 | pre-Alpha |
For one index case, the whole genome sequencing failed due to low viral RNA content in the sample; I Pango lineage nomenclature https://cov-lineages.org/index.html, accessed on 28 September 2021; # Period; pre-Alpha and Alpha reflects the period before and after the Alpha variant (B.1.1.7) was established (August–February versus March–May); * The following SARS-CoV-2 lineages occurred in only one index case each: B.1, B.1.1.39, B.1.1.277, B.1.177.44, B.1.177.82, B.1.177, and B.1.36.1.
SARS-CoV-2 variants in contact investigations in which primary and secondary cases were detected (n, 8), Oslo and Viken, August 2020–May 2021.
| ID | Period | School-Grade | SARS-CoV-2 Variant | SNP | ||
|---|---|---|---|---|---|---|
| Index | Primary Case II | Secondary Case III | ||||
| 08 | pre-Alpha | 1–4 | K.3 | K.3 | 2 SNPs | |
| 14 | pre-Alpha | 5–7 | B.1.1 | B.1.1 | B.1.1 | 0 SNP |
| 17 | pre-Alpha | 8–10 | B.1.36.21 | B.1.36.21 | 1 SNP | |
| 24 | pre-Alpha | 5–7 | B.1.1.305 | B.1.1.305 | 1 SNP | |
| 28 | pre-Alpha | 8–10 | B.1.1.305 | WGS failed | na | |
| 30 | pre-Alpha | 8–10 | B.1.36.21 | B.1.1.333 | na | |
| 33 | Alpha | 8–10 | B.1.1.7 | na | ||
| 41 | Alpha | 5–7 | B.1.1.7 | WGS failed | na | |
ID; identifier for each contact-investigation (reference, Appendix A Table A2); Period; pre-Alpha and Alpha reflects the periods before and after the Alpha variant (B.1.1.7) was established (August–February versus March–May); SNP; Single nucleotide polymorphism; I The index case was the child first identified with confirmed SARS-CoV-2 leading to the contact-investigation; II A contact of the index case who tested positive for SARS-CoV-2 in the first saliva sample; III A contact of the index case who tested positive for SARS-CoV-2 in the second saliva sample, following a first negative test.
Figure 1Maximum likelihood phylogenetic tree of SARS-CoV-2 strains from cases included in contact investigations (n, 33), Oslo and Viken, August 2020–May 2021; SNP; single nucleotide polymorphism; the whole genome sequencing failed due to low viral load in two of the secondary cases, and one the index case did not consent to participate.
Infection Prevention and Control (IPC) measures.
| ID | Quarter | Grade | National Guideline/Traffic Light Model | Sum of Scores | National Guidelines | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | B | C | D | E | F | G | H | ||||||
| 1 | Q3-2020 | 1–4 | 7 | ||||||||||
| 2 | 5–7 | 7 | |||||||||||
| 3 | 1–4 | 7 | |||||||||||
| 4 | 1–4 | 4 | |||||||||||
| 5 | Q4-2020 | 1–4 | 5 | ||||||||||
| 6 | 1–4 | 7 | |||||||||||
| 7 | 1–4 | 7 | |||||||||||
| 8 | 1–4 | 6 | |||||||||||
| 9 | 5–7 | 6 | |||||||||||
| 10 | 5–7 | 6 | |||||||||||
| 11 | 5–7 | 6 | |||||||||||
| 12 | 1–4 | 5 | |||||||||||
| 13 | 8–10 | 5 | |||||||||||
| 14 | 5–7 | 6 | |||||||||||
| 15 | 5–7 | 5 | |||||||||||
| 16 | 8–10 | 7 | |||||||||||
| 17 | 8–10 | 6 | |||||||||||
| 18 | 8–10 | 5 | |||||||||||
| 19 | 1–4 | 6 | |||||||||||
| 20 | 8–10 | 5 | |||||||||||
| 21 | 8–10 | 6 | |||||||||||
| 22 | 5–7 | 7 | |||||||||||
| 23 | 8–10 | 8 | |||||||||||
| 24 | 5–7 | - | |||||||||||
| 25 | 8–10 | - | |||||||||||
| 26 | 8–10 | 8 | |||||||||||
| 27 | 5–7 | 7 | |||||||||||
| 28 | Q1-2021 | 8–10 | 7 | ||||||||||
| 29 | 8–10 | 8 | |||||||||||
| 30 | 8–10 | 6 | |||||||||||
| 31 | 5–7 | 7 | |||||||||||
| 32 | 5–7 | 7 | |||||||||||
| 33 | 8–10 | 7 | |||||||||||
| 34 | 8–10 | 7 | |||||||||||
| 35 | Q2-2021 | 1–4 | - | ||||||||||
| 36 | 1–4 | 7 | |||||||||||
| 37 | 5–7 | 8 | |||||||||||
| 38 | 1–4 | 8 | |||||||||||
| 39 | 5–7 | - | |||||||||||
| 40 | 1–4 | 7 | |||||||||||
| 41 | 5–7 | 7 | |||||||||||
| 42 | 1–4 | 7 | |||||||||||
| 43 | 1–4 | 8 | |||||||||||
| Yellow level according to traffic light model | A | Stay at home policy for all if symptomatic | |||||||||||
| B | Enforced classroom hygiene | ||||||||||||
| Red level according to traffic light model | C | Defined child cohorts, reduced mixing of cohorts | |||||||||||
| D | Avoid shared spaces for children indoors | ||||||||||||
| IPC consistent with national guideline, score = 1 | E | Avoid shared spaces for children outdoors | |||||||||||
| F | Reduce the number of staff contacts per child | ||||||||||||
| IPC not consistent with national guideline, score = 0 | G | Reduce physical contact between staff | |||||||||||
| H | Promotion of home-office whenever possible | ||||||||||||
ID; identifier of each contact-investigation, IPC; Infection Prevention and Control measures.